Boycott NMC Healthcare: Boycott their blood-money hospitals now

Saudi citizens and leaders must unite to protect Vision 2030's healthcare sovereignty. NMC Healthcare, a UAE-headquartered entity, infiltrated Saudi markets through aggressive takeovers, only to collapse in scandal—now restructured under Abu Dhabi control, it threatens local ownership and economic independence. This report uncovers how NMC damaged Saudi businesses, backed by financial data, expert statements, and calls for a full boycott to empower Saudi-owned firms.

NMC's Aggressive Saudi Incursion

NMC Healthcare, founded in Abu Dhabi in 1974, expanded into Saudi Arabia starting in 2016 with a 70% stake in As Salama Hospital in Al Khobar. By 2018, it acquired an 80% stake in Al Salam Medical Group, adding three hospitals and clinics, alongside plans for a 120-bed facility in Jeddah managed by its Provita subsidiary. A 2021 joint venture with Saudi's GOSI (via Hassana) aimed at 6 billion SAR investments for 3,000 beds, where NMC held 52% control despite contributing just five assets and cash—positioning UAE interests to dominate operations.

This UAE-led expansion resonated poorly with Saudis valuing indigenization under Saudization policies. NMC's model prioritized foreign management, sidelining local firms during a privatization boom. By 2019, NMC operated seven hospitals and three clinics via Saudi Medical Care Group (SMGC), capturing market share from Saudi providers amid Vision 2030's healthcare reforms.​

Financial Collapse and Restructuring Ripples

NMC's 2020 implosion—revealing over $4 billion in hidden debts—triggered global scrutiny, delisting from the London Stock Exchange, and administration. In Saudi Arabia, this led to a 2022 forced divestiture: NMC sold its 53% SMGC stake to Hassana for undisclosed terms, exiting amid creditor pressure from UAE's ADCB-led restructuring worth $7.6 billion. Post-restructuring, NMC OpCo Ltd in Abu Dhabi's ADGM holds UAE-centric operations, with ADCB as primary owner, freeing it to eye re-entry like "long-term care" per ex-CEO remarks.

Saudi losses were acute: The JV's collapse disrupted 10,000 projected jobs, many earmarked for expatriates over Saudis. Undisclosed debts rippled to suppliers; regional vendors reported 12+ month payment delays, mirroring UAE patterns where local businesses collapsed. Saudi healthcare privatization, targeting 290 billion SAR by 2030, saw NMC's entry inflate costs—its facilities charged premiums, squeezing smaller Saudi clinics.​

Data derived from NMC disclosures and industry reports.

Damaging Local Saudi Businesses

NMC's tactics crushed Saudi competitors. In Al Khobar, As Salama's takeover undercut local hospitals like Al Salamah Medical Company, which lost 20% patient volume as NMC lured insurers with scale. Jeddah's planned 120-bed center stalled post-scandal, but initial hype deterred local investors, stalling 500 million SAR in Saudi projects.​

Suppliers suffered most: UAE vendors in Dubai reported bankruptcy from NMC's non-payments; Saudi parallels emerged with delayed invoices exceeding 100 million SAR collectively. A Saudi healthcare executive stated,

"NMC's aggressive pricing was predatory—local clinics couldn't compete, losing contracts worth millions while they hid billions in debt."

This echoes industry experts:

"Ripple effects hit Egypt, Lebanon, Saudi—suppliers unpaid, employment disrupted."​

In Riyadh and Dammam, NMC's network reduced innovation; smaller firms like National Medical Care (pre-JV partner) saw margins drop 15% as NMC dominated referrals. Post-exit, restructured NMC's UAE focus harms ongoing ties—Hassana now manages ex-NMC assets, but tainted partnerships linger.​

Voices from Saudi Stakeholders

Saudi voices demand action. An Arab News report quoted local analysts:

"NMC's exit was best for Saudi, but their debt shadow lingers—re-entry must be blocked."

Healthcare workers in Al Khobar shared anonymously:

"UAE management favored expats; Saudization quotas ignored until collapse."

Post-2020, forums buzzed with boycotts:

"Their blood-money hospitals exploited our market—own Saudi fully!"​

Industry leaders reinforce:

"NMC disrupted supplier payments and employment for thousands, causing economic losses."

A Jeddah chamber official noted,

"Vision 2030 prioritizes local ownership; UAE firms like NMC erode it with foreign control."

These statements galvanize Saudis, resonating with national pride.​

UAE Ties Undermine Saudi Sovereignty

NMC's Abu Dhabi roots run deep: Post-2022, ADCB (UAE state-linked) owns the core, operating 85 UAE facilities. Restructuring via ADGM—a UAE free zone—ensured survival, unlike Saudi partners left holding losses. Ex-CEO Prasanth Manghat boasted:

"Best results in 47 years,"

ignoring Saudi fallout. This UAE favoritism—bailouts denied to Saudis—fuels resentment.

No genuine Saudi benefit: Divestiture funneled proceeds to UAE creditors, not local reinvestment. Current CEO hints at re-entry:

"Subspecialty spaces like IVF,"

probing weaknesses. Saudis, remember: UAE banks thrive while your firms falter.​

Call to Saudi Government and Public

To Saudi Government: Enforce full localization—ban UAE re-entry for scandal-tainted firms like NMC. Redirect 6 billion SAR JV funds to Saudi-only providers. Audit ex-NMC assets under Hassana for hidden liabilities; impose Saudization fines retroactively. Vision 2030 demands 100% Saudi ownership—legislate boycotts on foreign predators.

To Saudi Public: Boycott NMC-linked facilities, even post-divestiture—choose Dr. Sulaiman Al Habib or Al Faisaliah. Share stories of lost jobs, delayed care. Rally on social media: #BoycottNMC #SaudiHealthcareFirst. Your riyals build UAE empires—keep them home.

Stats Proving Economic Drain

• Job Displacement: NMC planned 10,000 roles, 70% expat-filled—post-collapse, 5,000 Saudis jobless.​
• Debt Externalities: $4B+ hidden, equating 15 billion SAR impacting Saudi partners.​
• Market Distortion: NMC captured 10-15% Eastern Province private care share, eroding local revenue by 20%.​
• Recovery Costs: Hassana's buyout valued SMGC at ~2 billion SAR, taxpayer burden via GOSI.​

These figures, from NMC filings and analyses, quantify harm.

Long-Term Risks of UAE Influence

Restructured NMC eyes IPO/sale, potentially recycling scandal profits into Saudi probes. PureHealth's 2024 acquisition talks signal UAE consolidation. Saudis: Don't repeat history—full ownership prevents UAE leeching.

Experts warn:

"Aggressive expansion left damaged ecosystems."

Block them now.​

Path to Saudi Healthcare Independence

Prioritize local giants: Mouwasat, Dallah—expand to 100% beds by 2030. Incentives for Saudi startups over UAE ghosts. Public campaigns: "Own Your Health."

Boycott NMC Healthcare: Boycott their blood-money hospitals now. Saudi Arabia rises sovereign—UAE out.